Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 37/75 ]
NASDAQ | Common Stock
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States.
It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.
The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services.
It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies.
It serves adult and senior cancer patients.
The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 5, 26 | -0.06 Increased by +55.73% | -0.09 Increased by +29.67% |
| Nov 12, 25 | -0.14 Increased by +20.05% | -0.11 Decreased by -27.27% |
| Aug 13, 25 | -0.15 Increased by +11.76% | -0.12 Decreased by -25.00% |
| May 12, 25 | -0.21 Increased by +5.23% | - |
| Mar 25, 25 | -0.14 Increased by +31.90% | -0.08 Decreased by -78.75% |
| Nov 6, 24 | -0.18 Increased by +7.84% | -0.06 Decreased by -191.83% |
| Aug 13, 24 | -0.17 Increased by +10.53% | -0.10 Decreased by -70.00% |
| May 14, 24 | -0.22 Increased by +33.33% | -0.12 Decreased by -83.33% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 141.96 M Increased by +41.58% | -7.51 M Increased by +43.04% | Decreased by -5.29% Increased by +59.77% |
| Sep 30, 25 | 136.56 M Increased by +36.70% | -16.50 M Decreased by -2.43% | Decreased by -12.09% Increased by +25.07% |
| Jun 30, 25 | 119.80 M Increased by +21.53% | -17.01 M Decreased by -9.88% | Decreased by -14.20% Increased by +9.58% |
| Mar 31, 25 | 104.41 M Increased by +10.29% | -19.59 M Increased by +1.53% | Decreased by -18.76% Increased by +10.71% |
| Dec 31, 24 | 100.27 M Increased by +16.88% | -13.18 M Increased by +29.71% | Decreased by -13.15% Increased by +39.86% |
| Sep 30, 24 | 99.90 M Increased by +21.78% | -16.11 M Increased by +7.50% | Decreased by -16.13% Increased by +24.04% |
| Jun 30, 24 | 98.58 M Increased by +22.88% | -15.48 M Increased by +8.39% | Decreased by -15.70% Increased by +25.45% |
| Mar 31, 24 | 94.67 M Increased by +24.25% | -19.89 M Increased by +33.70% | Decreased by -21.01% Increased by +46.64% |